# A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis

> **NCT02193815** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 15 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** PF06263276
- **OTHER:** Vehicle
- **DRUG:** 2%Tofacitinib Ointment
- **OTHER:** Vehicle
- **DRUG:** Daivonex
- **DRUG:** Daivonex Ointment

## Key facts

- **NCT ID:** NCT02193815
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193815, "A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02193815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*